When.com Web Search

  1. Ads

    related to: humira success rate for crohn's 7

Search results

  1. Results From The WOW.Com Content Network
  2. Adalimumab - Wikipedia

    en.wikipedia.org/wiki/Adalimumab

    Adalimumab, sold under the brand name Humira and others, is a disease-modifying antirheumatic drug and monoclonal antibody used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis.

  3. TNF inhibitor - Wikipedia

    en.wikipedia.org/wiki/TNF_inhibitor

    A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory response.TNF is involved in autoimmune and immune-mediated disorders such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, psoriasis, hidradenitis suppurativa and refractory asthma, so TNF inhibitors may be used in their ...

  4. Management of Crohn's disease - Wikipedia

    en.wikipedia.org/wiki/Management_of_Crohn's_disease

    Vedolizumab is a gut-selective, Alpha-4 Beta-7 anti-integrin, monoclonal antibody that was approved by the U.S. Food and Drug Administration to treat Crohn's disease in 2014. It is indicated for management of moderate-to-severe, active Crohn's disease patients and it works by inhibiting the trafficking of pro-inflammatory immune cells to the ...

  5. AbbVie's tight grip on Humira market raises concerns about ...

    www.aol.com/news/abbvies-tight-grip-humira...

    AbbVie’s top-selling arthritis drug Humira has held onto more than 80% of patients after facing nine lower-priced rivals in the U.S. in the last year, raising questions about whether the market ...

  6. Humira's Sales Will Decline -- and It's Fantastic News for AbbVie

    www.aol.com/news/humira-apos-sales-decline-apos...

    Even with falling sales, Humira should still rank as the top-selling drug in the world in 2024.

  7. AbbVie's Humira Still a Growth Engine - AOL

    www.aol.com/news/2014-03-08-abbvies-humira-still...

    A recently published report by global pharma researcher Decision Resources suggests that forward growth in key European markets for AbbVie's flagship drug Humira, a treatment for autoimmune ...

  1. Ads

    related to: humira success rate for crohn's 7